Non-Invasive Genomic Biomarker Monitoring to Improve Long-Term Transplant Outcomes

Biomarker Science

Healthcare Professionals

Patients & Caregivers

Transplant Genomics aims to improve transplant outcomes through molecular diagnostic tests that detect early signs of graft injury, differentiate among actionable causes, and enable optimization of therapy.

~35% of patients receive a surveillance biopsy in the first year

≥75% of patients who have surveillance biopsies show normal histology, and the vast majority could have been spared an invasive procedure

≥20% of patients show subclinical acute rejection

Transplant Genomics’ novel biomarker assays aid physicians with non-invasive monitoring to improve long-term transplant outcomes.